Expert corner - diabetic retinopathy
Diabetic retinopathy (DR) continues to be a challenge both to clinicians and patients. The systemic variables involved, local mediators implicated, and the coexistence of other ocular conditions such as cataract requires careful planning and delivery of treatment. With the advent of antivascular end...
Main Authors: | R Kim, Atul Kumar, Rajiv Raman, Raja Narayanan, Manish Nagpal, Paisan Ruamviboonsuk, V G Madanagopalan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | TNOA Journal of Ophthalmic Science and Research |
Subjects: | |
Online Access: | http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2019;volume=57;issue=2;spage=146;epage=151;aulast=Kim |
Similar Items
-
Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines
by: Taraprasad Das, et al.
Published: (2016-01-01) -
Intravitreal Bevacizumab (Avastin) in Treatment of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
by: Attaullah Shah Bukhari, et al.
Published: (2018-06-01) -
Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
by: Tsubota K, et al.
Published: (2019-06-01) -
New Insights into Treating Early and Advanced Stage Diabetic Retinopathy
by: Rafael Simó, et al.
Published: (2022-07-01) -
The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors
by: Al-Dwairi RA, et al.
Published: (2024-03-01)